PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis
Pei Wu1, Jinou Wang2, Xiaoyun Mao3
1Department of Surgical Oncology, Department of General Surgery, First Affiliated Hospital, China Medical University, Shenyang, China.
Objective:
Programmed cell death 4 (PDCD4) is a tumor suppressor gene, however, the function and regulatory mechanism remain to be discovered. The connection between tumorigenesis and apoptosis is one of the most important foci of cancer research. Our study aimed to explore the connections between PDCD4-mediated apoptosis of human peritoneal mesothelial cells (HPMC) and peritoneal metastasis in gastric cancer.
Methods:
The PDCD4 expression in 31 pairs of HPMC and tumor tissues was assessed by immunohistochemistry and RT-PCR. In cell experiments, we monitored gastric cancer cell migration with a Transwell chamber assay when PDCD4 was silenced in HPMC. Subsequently, apoptosis of HPMC was detected by a flow cytometric assay and western blotting. After analyzing cytokines in culture supernatants from gastric cancer with enzyme-linked immunosorbent assays (ELISAs), transforming growth factor-beta 1 (TGF-β1) was abundant in the culture supernatants of gastric cancer. Then, PDCD4 expression in HMrSV5 cells was analyzed by western blotting after retreatment with different concentrations of TGF-β1. Moreover, apoptosis of peritoneal mesothelial cells treated with TGF-β1 was detected according to the above methods.
Results:
In human metastatic peritoneal tissues, the expression of PDCD4 was significantly lower than that in normal tissues. At the same time, decreased expression of PDCD4 in HPMC was associated with increased migration capacity of gastric cancer cells. Moreover, suppressing the expression of PDCD4 promoted apoptosis in mesothelial cells which may be regulated by TGF-β secreted from gastric cancer cells.
Conclusions:
These data suggested that decreased expression of PDCD4 significantly promoted apoptosis in human peritoneal mesothelial cells, thus inducing peritoneal metastasis, and that TGF-β1 secreted from gastric cancer cells may have played a crucial role.
Insights
Decreased programmed cell death 4 (PDCD4) in human peritoneal mesothelial cells (HPMC) promotes gastric cancer metastasis. Transforming growth factor-beta 1 (TGF-β1) secreted by cancer cells may induce this apoptosis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Mechanisms of Cancer
Background:
- Programmed cell death 4 (PDCD4) is a tumor suppressor gene with incompletely understood functions.
- The interplay between tumorigenesis and apoptosis is critical in cancer research.
- Understanding PDCD4's role in peritoneal metastasis is essential.
Purpose of the Study:
- To investigate the link between PDCD4-mediated apoptosis in human peritoneal mesothelial cells (HPMC) and gastric cancer peritoneal metastasis.
- To explore the regulatory mechanisms of PDCD4 in this context.
Main Methods:
- Assessed PDCD4 expression in HPMC and tumor tissues using immunohistochemistry and RT-PCR.
- Utilized Transwell assays to monitor gastric cancer cell migration after PDCD4 silencing in HPMC.
- Detected HPMC apoptosis via flow cytometry and western blotting.
- Quantified cytokines, including transforming growth factor-beta 1 (TGF-β1), using ELISAs.
- Analyzed PDCD4 expression and HPMC apoptosis following TGF-β1 treatment.
Main Results:
- PDCD4 expression was significantly lower in human metastatic peritoneal tissues compared to normal tissues.
- Reduced PDCD4 expression in HPMC correlated with increased gastric cancer cell migration.
- Suppression of PDCD4 expression induced apoptosis in mesothelial cells, potentially regulated by TGF-β secreted from gastric cancer cells.
Conclusions:
- Decreased PDCD4 expression in HPMC significantly promotes apoptosis, contributing to peritoneal metastasis in gastric cancer.
- TGF-β1 secreted by gastric cancer cells appears to play a crucial role in this process.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity


